“Treat-to-Target Outcomes and Measures of Treatment Success in Three Phase 3 Trials of Tapinarof Cream 1% Once Daily for Mild to Severe Plaque Psoriasis”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): s52. https://doi.org/10.25251/skin.6.supp.52.